IHS Chemical Week

Regions :: North America

Lonza Acquires U.S. Contract Manufacturer

11:42 PM MDT | August 30, 2010 | Deepti Ramesh

Lonza says it has entered the viral-based manufacturing market with its acquisition of Vivante GMP Solutions (Houston, TX). Vivante is a custom manufacturing organization producing viral-based therapeutics, and the acquisition advances Lonza’s strategy to broaden its biologics custom service offering for the growing viral vaccine and gene therapy markets, Lonza says. Financial terms of the acquisition were not disclosed. “Lonza is strategically committed to being successful in the growing viral marketplace,” says David Smith, head of Therapeutic...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa